›
Amgen Inc
MVASI (bevacizumab) Injection 400 mg/16 mL Single-Dose Vial
No image availableWe couldn't find a product image for this item.
MVASI is a biosimilar to Avastin (bevacizumab), supplied as a sterile, preservative-free solution for intravenous infusion. Each 16 mL single-dose vial contains 400 mg of bevacizumab. It is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and others.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
1 vendor
Henry Schein Dental
Best Pricex Out of Stock
$2790.89
No image availableWe couldn't find a product image for this item.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
1 vendor
Henry Schein Dental
Best Pricex Out of Stock
$2790.89
MVASI is a biosimilar to Avastin (bevacizumab), supplied as a sterile, preservative-free solution for intravenous infusion. Each 16 mL single-dose vial contains 400 mg of bevacizumab. It is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and others.
$2790.89
1 vendor
